Addex Therapeutics to Participate in the BTIG Virtual Biotechnology Conference 2020

Van Leeuwenhoeck Issues Updated Addex Equity Research Report

Addex mGlu2 PAM Program to Advance into Epilepsy Phase 2a Proof of Concept Clinical Study

Addex Shareholders Approve All Resolutions at Annual General Meeting

Addex Reports Q1 2020 Financial Results and Provides Corporate Update

Addex Therapeutics Establishes Scientific Advisory Board

Addex Reports 2019 Full Year Audited Results and Provides Corporate Update

Addex Therapeutics to Report 2019 Full Year Audited Results on April 8, 2020

Addex Therapeutics Delays Start of Dipraglurant Pivotal Study and Reporting 2019 Full Year Audited Results

Addex Therapeutics to Report 2019 Full Year Audited Results on March 19, 2020